• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 23, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

APS and IOP Publishing commit to ORCID scheme for unambiguously identifying contributors

Bioengineer by Bioengineer
July 18, 2017
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The American Physical Society (APS) and IOP Publishing (IOPP) have signed up to the ORCID Open Letter, committing to collecting ORCID iDs for authors submitting to their journals following stated best practices.

ORCID (Open Researcher and Contributor ID) is a not-for-profit organization that provides a unique digital name, or iD, which identifies researchers and scholars, and distinguishes them from others with similar names. By connecting this iD to all their research activities, publications, and affiliations, researchers will benefit from improved recognition, reduce reporting burdens, and can ensure they get full credit for their work.

APS Publisher Matthew Salter said, "ORCID iDs will make a huge difference to the research community when it comes to being accurately credited for their work, and in tracking their publications over the course of their careers.

"With several major funders now requiring ORCID iDs as part of their grant application process, we hope that this will reduce the administrative burden on researchers as well as providing scholarly benefits."

Jamie Hutchins, Publishing Director for IOP Publishing, said, "By signing the ORCID Open Letter, IOP Publishing and the APS together aim to improve the experience of the scholarly publishing process for researchers in the fields we represent.

"It is extremely important that researchers are correctly recognized for their work, whether as an author, reviewer or editor, and that the community is able to cite work without confusion. ORCID identifiers make this easier, by removing the confusion that can be caused by similarities between researchers' names, name changes, inconsistencies in abbreviations, and cultural differences in how names are presented."

Laurel Haak, Executive Director of ORCID, welcomed APS and IOP engagement with ORCID. "As the main publishers in the physical sciences, use of ORCID iDs by APS and IOP means that authors will be clearly attributed and their body of work more easily discoverable."

APS and IOP Publishing and will collect ORCID iDs for all corresponding authors through the ORCID API, and will display the identifiers in articles published in their journals.

###

About APS

The American Physical Society is a nonprofit membership organization working to advance and diffuse the knowledge of physics through its outstanding research journals, scientific meetings, and education, outreach, advocacy, and international activities. APS represents over 54,000 members, including physicists in academia, national laboratories, and industry in the United States and throughout the world. Society offices are located in College Park, MD (Headquarters), Ridge, NY, and Washington, D.C.

Media Contact

James Riordon
[email protected]
301-209-3238
@APSphysics

http://www.aps.org

http://www.aps.org/newsroom/pressreleases/orcid-scheme.cfm

Share12Tweet8Share2ShareShareShare2

Related Posts

Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

August 23, 2026

ZCCHC4 boosts replication-dependent histone mRNA translation by interacting with eIF3

August 23, 2026

Tirzepatide Versus GLP-1 Agonists for Stroke Risk in Atrial Fibrillation and Diabetes

August 22, 2026

Real-world study examines psychotic complications of subcutaneous foslevodopa/foscarbidopa infusions in 198 patients

August 22, 2026
Please login to join discussion

POPULAR NEWS

  • Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

    29 shares
    Share 12 Tweet 7
  • ZCCHC4 boosts replication-dependent histone mRNA translation by interacting with eIF3

    29 shares
    Share 12 Tweet 7
  • KAIST Surface Defects Boost Droplet Formation, Removal, and Heat Transfer by 5.5-Fold

    29 shares
    Share 12 Tweet 7
  • Dual-oxygen pancreatic cancer organoids mirror basal-classical diversity, spatial transcriptomics confirms

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

ZCCHC4 boosts replication-dependent histone mRNA translation by interacting with eIF3

KAIST Surface Defects Boost Droplet Formation, Removal, and Heat Transfer by 5.5-Fold

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.